AbbVie Takes Aim at Vertex Pharmaceuticals Incorporated

At the moment, treatment options for cystic fibrosis are limited to drugs marketed by Vertex Pharmaceuticals Inc. (NASDAQ: VRTX), but a deep-pocketed drugmaker just took a big step toward entering the space.